DR. ZANETTA STEWART LAMAR M.D. NPI 1871776757

NPI Details

DR. Zanetta Stewart Lamar, M.D. is a medical oncology internal medicine in Naples, FL with 19 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Zanetta Stewart Lamar, M.D. NPI is 1871776757. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: MEHARRY MEDICAL COLLEGE SCHOOL OF MEDICINE
Graduation Year:2007

The provider's business location address is:

708 GOODLETTE RD NORTH
SUITE 200, 2ND FLOOR
NAPLES, FL
ZIP 34102-644
Phone: (239) 231-7260

The NPI 1871776757 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Iron binding capacity (HCPCS:83550)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection of drug or substance into vein (HCPCS:96374)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Magnesium level (HCPCS:83735)
• Protein measurement, serum (HCPCS:84165)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Injection, furosemide, up to 20 mg (HCPCS:J1940)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Uric acid level, blood (HCPCS:84550)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Phosphate level (HCPCS:84100)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Automated urinalysis test (HCPCS:81003)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Erythropoietin (protein) level (HCPCS:82668)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Hemoglobin a1c level (HCPCS:83036)

The enumeration date for this NPI number is 12/13/2007 and was last updated on 2/5/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.